GlassScriptPhysician profile
Sharon Henn
NPI 1700307832
$19,095.29
in general payments reported to CMS, 2019-2025
57 companies · $3,845 in 2025
The $3,845 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,027 · 2022: $4,104 · 2023: $4,986 · 2024: $3,133 · 2025: $3,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $3.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,960.91 |
| Education | $3.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $2,602.20 | 2021-2025 | Vumerity, Tysabri, Tysabri |
| Abbvie INC. | $1,655.00 | 2021-2025 | |
| Emd Serono, INC. | $1,621.13 | 2022-2025 | Mavenclad, Mavenclad |
| Novartis Pharmaceuticals Corporation | $1,365.06 | 2021-2025 | |
| Genzyme Corporation | $1,059.74 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $784.89 | 2021-2025 | Ultomiris, Soliris |
| Eisai INC. | $679.89 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $594.33 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $575.72 | 2021-2023 | Austedo Xr, Austedo |
| Janssen Pharmaceuticals, INC | $549.07 | 2021-2022 | |
| Sk Life Science, INC. | $548.16 | 2021-2025 | Xcopri |
| Lundbeck LLC | $542.69 | 2021-2025 | Vyepti, Rexulti |
| Genentech USA, INC. | $503.30 | 2021-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Neurocrine Biosciences, INC. | $501.54 | 2021-2024 | Ingrezza, Ongentys |
| Lilly USA, LLC | $465.11 | 2022-2025 | Amyvid, Kisunla, Emgality |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $442.29 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Ucb, INC. | $427.32 | 2021-2025 | Nayzilam, Briviact, Zilbrysq |
| Pfizer INC. | $409.18 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $361.42 | 2021-2025 | Rexulti, Nuedexta |
| Amneal Pharmaceuticals LLC | $299.76 | 2022-2025 | Crexont, Rytary, Lyvispah |
| Banner Life Sciences, LLC | $279.23 | 2022-2024 | |
| Livanova USA, INC. | $254.08 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Horizon Therapeutics Plc | $249.98 | 2022-2023 | Uplizna |
| Acadia Pharmaceuticals INC | $228.25 | 2023-2025 | Nuplazid |
| Celgene Corporation | $227.50 | 2021-2025 | Zeposia |
| Amgen INC. | $189.49 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $150.81 | 2022 | |
| Neurelis, INC. | $149.41 | 2022-2023 | Valtoco |
| Acorda Therapeutics, INC | $136.13 | 2021-2023 | Ampyra, Inbrija |
| Corium, LLC | $130.62 | 2022-2023 | Adlarity, Azstarys |
| Janssen Biotech, INC. | $102.71 | 2025 | |
| Aucta Pharmaceuticals, INC. | $101.83 | 2024-2025 | Motpoly Xr |
| Mdd US Operations, LLC | $74.32 | 2022-2024 | Apokyn, Apokyn |
| Alnylam Pharmaceuticals INC. | $68.09 | 2023 | Onpattro |
| Ironshore Pharmaceuticals INC. | $62.84 | 2022-2023 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $61.50 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $52.39 | 2021 | |
| Tg Therapeutics, INC. | $52.38 | 2023-2024 | |
| Csl Behring | $46.67 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $44.24 | 2021 | |
| Axsome Therapeutics, INC. | $41.35 | 2023 | Sunosi |
| Tanabe Pharma America, INC. | $39.71 | 2021-2025 | Radicava |
| Allergan, INC. | $38.78 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $36.03 | 2024 | Zeposia |
| Upsher-Smith Laboratories LLC | $32.64 | 2021 | |
| Kyowa Kirin, INC. | $32.39 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $29.00 | 2022 | |
| Avanir Pharmaceuticals, INC. | $26.87 | 2022 | |
| Avion Pharmaceuticals | $24.21 | 2022 | |
| Cala Health, INC. | $22.96 | 2025 | Cala Kiq |
| Astrazeneca Pharmaceuticals LP | $20.01 | 2023 | Evusheld |
| Merz Pharmaceuticals, LLC | $19.17 | 2022 | |
| Emmaus Medical, INC. | $18.31 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.64 | 2022 | |
| Impel Pharmaceuticals INC. | $16.96 | 2023 | Trudhesa |
| Cycle Pharmaceuticals INC | $15.57 | 2025 | Tascenso Odt |
| Alfasigma USA, INC. | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Henn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.